Maralixibat 9.5 Mg/mL Sol Oral Fr 30 mL
TED · 498789-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€1,435,097 · 1,435,097.4 EUR
WinnerCencora 3PL Portugal, S.A.
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 1 | €1,899,000 | 2026-06-19 |
| Takeda Farmacêuticos Portugal, Lda | 1 | €1,828,250 | 2026-07-17 |
| Getinge Group Portuga, Unipessoal, Lda. | Iberdata Equipamentos, SA | 1 | €1,412,619 | 2026-05-21 |
| General Electric Healthcare Portugal, Sociedade Unipessoal, Lda, | 1 | €851,700 | 2026-06-02 |
| Med-El GmbH Portugal | 1 | €730,840 | 2026-07-17 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição do medicamento "Maralixibat 9.5 Mg/mL Sol Oral Fr 30 mL"
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-02 | 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-05-12 | 2023/0491 - PEMBROLIZUMAB [25 MG/ ML 4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-06-24 | 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-06-30 | 2023/0491 - AVELUMAB [20 MG/ ML 10 ML FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 91% |